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SUMMARY
Microalgae constitute a diverse group of eukaryotic unicellular organisms that are of interest for pure and
applied research. Owing to their natural synthesis of value-added natural products microalgae are emerging as
a source of sustainable chemical compounds, proteins and metabolites, including but not limited to those that
could replace compounds currently made from fossil fuels. For the model microalga, Chlamydomonas rein-
hardtii, this has prompted a period of rapid development so that this organism is poised for exploitation as an
industrial biotechnology platform. The question now is how best to achieve this? Highly advanced industrial
biotechnology systems using bacteria and yeasts were established in a classical metabolic engineering man-
ner over several decades. However, the advent of advanced molecular tools and the rise of synthetic biology
provide an opportunity to expedite the development of C. reinhardtii as an industrial biotechnology platform,
avoiding the process of incremental improvement. In this review we describe the current status of genetic
manipulation of C. reinhardtii for metabolic engineering. We then introduce several concepts that underpin
synthetic biology, and show how generic parts are identified and used in a standard manner to achieve pre-
dictable outputs. Based on this we suggest that the development of C. reinhardtii as an industrial biotechnol-
ogy platform can be achieved more efficiently through adoption of a synthetic biology approach.
Keywords: synthetic biology, industrial biotechnology, Chlamydomonas reinhardtii, metabolic engineering,
rational design, transgene expression.
MICROALGAE PRESENT UNIQUE FEATURES FOR APPLIED
RESEARCH AND BIOTECHNOLOGY
Microalgae are a polyphyletic group of unicellular eukary-
otic organisms that can occupy both aquatic and terrestrial
environments, adopting photosynthetic, heterotrophic or
mixotrophic lifestyles. The enormous diversity in the algal
lineages is due to their long evolutionary history (Dorrell
and Smith, 2011). For instance the green algae, which are
ancestral to land plants, diverged 1300 million years ago
from the stramenopiles (Yoon et al., 2004), a group that
encompasses several microalgal lineages of biotechnologi-
cal relevance such as diatoms. As a result, microalgae exhi-
bit wide variation in both cellular architecture and
biosynthetic capacity, and thus present a number of general
and unique features as research models and for commercial
exploitation. Specifically, the unicellular physiology com-
bined with rapid cell division and photosynthetic growth
mean that microalgae can be more productive per unit land
area than any plant system. In addition, using microalgae
as feedstocks for low value, high volume products such as
biofuels, provides the opportunity to avoid a number of
environmental factors that currently affect biofuel produc-
tion from crop plants (Chisti, 2007). These include issues
surrounding land and (fresh)water usage, mono-culture,
crop rotation, and input requirements: for example microal-
gae are able to sequester nitrogen and phosphorus from
industrial waste streams, thus reducing the need for fertilis-
ers. Nevertheless, many challenges remain to be overcome
before it will be possible to cultivate algae on the very large
scales needed for biofuel production (Scott et al., 2010;
Klein-Marcuschamer et al., 2013). Instead, microalgae offer
considerable potential for the production of low volume,
high(er) value compounds, which are characteristically pro-
duced by industrial biotechnology (IB). Moreover, the pho-
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tosynthetic lifestyle of microalgae means that they offer a
more sustainable source of compounds compared to bacte-
rial and yeast hosts used in conventional IB, since there is
no need to provide fixed carbon.
Currently microalgae are exploited commercially for
compounds that they make naturally, such as the pigments
b-carotene and astaxanthin, and polymers alginate, carra-
geenan and agar for food products. Several research stud-
ies have attempted to enhance the production of value-
added compounds, including bio-hydrogen from Chla-
mydomonas reinhardtii (Baltz et al., 2014; Xu et al., 2014),
or omega-3 long chain fatty acids such as docosahexanoic
acid (DHA) or eicosapentaenoic acid (EPA) from Phaeo-
dactylum tricornutum. Although P. tricornutum naturally
makes EPA and some DHA, levels are low and the ratio of
the two fatty acids is suboptimal for some commercial
applications. In addition, they are present mainly in mem-
brane rather than storage lipids, making extraction ineffi-
cient. Hamilton et al. (2014) were able to increase levels of
DHA in P. tricornutum eight-fold by heterologous expres-
sion of two fatty-acid modifying enzymes, a D5-elongase
and an acyl-CoA-dependent D6-desaturase, from the green
alga Ostreococcus tauri using a constitutive promoter.
Another desirable feature of microalgae is their cellular
complexity, which provides the opportunity to partition or
compartmentalise biochemical reactions, something not
possible in bacterial hosts. This can facilitate the provision
of precursors, or provide intracellular sinks for target prod-
ucts. Indeed, there are already reports of the production of
human therapeutic proteins including erythropoietin, inter-
feron b proinsulin and immunoglobulin A in the chloro-
plast of C. reinhardtii (Rasala et al., 2010).
Whilst the many benefits afforded by microalgae are yet
to be demonstrated at scale, these studies serve to raise the
profile of microalgae research and development. The chal-
lenge now lies in the application of metabolic engineering
strategies to enhance natural features of microalgae, mak-
ing commercial exploitation economically viable (Klein-
Marcuschamer et al., 2013). For example, in dense cultures
required for industrial cultivation, light capture is limited.
Reduction of the light-harvesting apparatus reduces light
absorption per cell, increasing penetration and productivity
within the culture (Polle et al., 2003; Cazzaniga et al., 2014).
Other targets for optimisation include resource-use effi-
ciency and auto-flocculation to facilitate harvesting. In par-
allel, to optimise and expand the level and range of novel
products made by microalgae, it will be necessary to intro-
duce new biosynthetic capabilities, remove competing
pathways, and optimise the provision of precursor sub-
strates and cofactors. Thus for microalgal IB to come of
age, we need a suite of molecular biological tools with
which to carry out sophisticated metabolic engineering.
For more than 20 years scientists have been able to redi-
rect the metabolism of a host cell in a targeted manner
through genetic manipulation, and this has been applied to
across the tree of life, in both prokaryotes and eukaryotes,
working with well characterised laboratory strains as well
as novel environmental isolates. In the commercial sector,
several organisms have been developed as robust IB hosts,
including bacteria (Escherichia coli, Bacillus subtilis, Cory-
nebacterium glutamicum, Lactobacillus spp.), and yeasts
and fungi (Saccharomyces cerevisiae, Aspergillus spp.).
These are used as production systems for compounds rang-
ing from organic acids to pharmaceutical proteins (Goel
et al., 2012; Buchholz and Collins, 2013). In spite of this suc-
cess, metabolic engineering seldom demonstrates the
design aspect that is so fundamental to engineering per se,
since the development of bespoke solutions for each experi-
mental system/product results in parallel development, and
limits the transferability of constructs and knowledge. The
advent of synthetic biology, whose principles involve a
combination of standard parts, predictive modelling, and
iterative design and testing, is just beginning to be
exploited in the field of metabolic engineering, and holds
out real promise for considerable advances in IB for produc-
tion of compounds to reduce reliance on fossil fuels as feed-
stocks (Keasling, 2012; Yadav et al., 2012).
In this review, we present an overview of what has been
achieved in terms of genetic manipulation of C. reinhardtii,
and frame this in the context of bacterial and yeast model
systems, drawing comparisons to illustrate current capabili-
ties and limitations. We then discuss the relevance and
timely nature of the development of synthetic biology con-
cepts for metabolic engineering and how this represents a
step change in capacity and predictive power. Finally we
highlight how, through relatively minor changes, synthetic
biology approaches might be applied to the development of
C. reinhardtii as an IB platform, and also to enhance the
microalgal research field more broadly. It is worth mention-
ing that other microalgae are being explored for similar
applications, and we direct the reader to excellent reviews
on the subject (Wijffels et al., 2013; Bellou et al., 2014; Klok
et al., 2014; Chauton et al., 2015). In addition, several cyano-
bacterial species are being used for metabolic engineering,
including for biofuels (Quintana et al., 2011; Berla et al.,
2013; Wijffels et al., 2013). As prokaryotes they are not
algae, but their simpler genetic system and ease of transfor-
mation can offer advantages. Conversely, they are less ver-
satile than algae in terms of metabolic pathways.
MOLECULAR RESOURCES FOR C. REINHARDTII
Chlamydomonas reinhardtii (Chlorophyta) is a photosyn-
thetic biflagellate microalga that has been studied for
>30 years as a model for basic and applied physiology and
biochemistry (see articles in the rest of this issue). The
number of resources available for the manipulation of
C. reinhardtii has increased markedly over this period
(Figure 1). These include well defined protocols for growth,
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sexual propagation, and mutagenesis, as well as numerous
published biochemical, analytical and reporter assays.
Supporting research into various aspects of cell biology is
the Chlamydomonas stock centre, a collection of >300 plas-
mids and >2700 strains (www.chlamy.org). Sequences of
the nuclear, chloroplast and mitochondrial genomes have
been completed (Merchant et al., 2007). The approximately
17 000 genes are well annotated, due to the substantial
amount of expression data available, as well as the efforts
of the community. The current nuclear genome database,
version 5.5, has had most gaps filled and is ~93% complete
(Blaby et al., 2014). This knowledge base is made accessi-
ble by web based tools including JGI Phytozome genome
browser (Goodstein et al., 2012), the functional genomic
ChlamyCyc portal (May et al., 2009), KEGG metabolic path-
way portal (Kanehisa, 2000), and the PlantGDB compara-
tive genomics resource (Duvick et al., 2008). The
complexity of cellular metabolism is made accessible in sil-
ico by the generation of genome-scale metabolic models
(GSMMs). GSMMs present a snapshot of metabolism in a
network format and allow the topology of system to be
investigated. Several GSMMs for C. reinhardtii have been
generated (Boyle and Morgan, 2009; Christian et al., 2009;
Manichaikul et al., 2009; Chang et al., 2011; Cogne et al.,
2011; Dal’Molin et al., 2011; Kliphuis et al., 2012), and the
efficacy of such models has been reviewed recently (Reijn-
ders et al., 2014).
Protocols for transformation of the nucleus, chloroplast
and mitochondria are available using biolistics (Debuchy
et al., 1989), electroporation (Shimogawara et al., 1998),
Agrobacterium (Kumar et al., 2004) or even simply vor-
texing with glass beads (Kindle, 1990). Facilitating nuclear
transformation is the availability of several selectable
markers, including auxotrophic markers, such as ARG7,
which restores arginine prototrophy (Debuchy et al., 1989;
Purton and Rochaix, 1995), as well as resistance genes,
BLE (resistance against phleomycin; Stevens et al., 1996),
APHVIII (paromomycin; Sizova et al., 1996), and HYG (hy-
gromycin B; Berthold et al., 2002). Transformation of the
chloroplast genome can be by homologous recombination,
enabling targeted and specific manipulation, although
because of the multiple copies of the chloroplast DNA, sev-
eral rounds of selection are required to obtain homo-
plasmy (Day and Goldschmidt-Clermont, 2011). Nuclear
transformation, on the other hand, is by random integra-
tion, and this means that multiple transformants must be
screened to obtain stable lines expressing the transgene at
the desired level (Debuchy et al., 1989). Important recent
developments include the generation of a knock-out library
consisting of >1600 single gene knockouts (Zhang et al.,
2014) and the description of two strains, generated by ran-
dom mutagenesis, which demonstrate enhanced protein
expression due to an unknown mechanism that reduces
the effects of transgene silencing (Neupert et al., 2009).
Complementing these resources are genomics stud-
ies of C. reinhardtii, of which there an increasing
number (Table 1), including several aimed at metabolic
Figure 1. The rise of C. reinhardtii as a model system for molecular
biology.
Major breakthroughs include first nuclear and chloroplast transformations
(Boynton et al., 1988; Blowers et al., 1989; Kindle et al., 1989), mitochondrial
transformation (Randolph-Anderson et al., 1993), systems analysis by prote-
omics (Hippler et al., 2001), the proposal of C. reinhardtii as a model organ-
ism (Harris, 2001), the production of the first therapeutic recombinant
protein in the chloroplast (Mayfield et al., 2003), the sequencing of the
nuclear genome (Merchant et al., 2007) and the publication of genome edit-
ing techniques (Sizova et al., 2013; Gao et al., 2014; Jiang et al., 2014) and
the creation of a knock-out collection (Zhang et al., 2014).
Table 1 Examples of genomic studies completed for the analysis
of specific physiological and biochemical characteristics of C. rein-
hardtii
Study Studies Reference
Microarrays Tandem repeat
discovery
Zhao et al. (2014a)
Sexual production Ning et al. (2013)
Transcriptomics Transcription factors Ria~no-Pachon
et al. (2008)
Alternative splicing Labadorf et al. (2010)
Polyadenylation Zhao et al. (2014b)
Growth adaptation
based on natural
selection,
serial dilution
Perrineau
et al. (2014)
TAG production
improvement
Goodenough
et al. (2014)
Flagella regeneration Stolc et al. (2005)
CO2 effect Fang et al. (2012)
Proteomics Basal body Keller et al. (2005)
Mitochondria van Lis et al. (2003)
Thylakoids Allmer et al. (2006)
Metabolomics ChlamyCyc database May et al. (2009)
Partitioning oil
and starch
Johnson and
Alric (2013)
S-deprived
H2 production
Matthew et al. (2009)
© 2015 The Authors
The Plant Journal published by Society for Experimental Biology and John Wiley & Sons Ltd.,
The Plant Journal, (2015), doi: 10.1111/tpj.12781
Chlamydomonas as an industrial biotechnology host 3
engineering. Matthew et al. (2009) analysed the metabolo-
me of C. reinhardtii following sulfur depletion. This analy-
sis demonstrated that between 0 and 24 h post sulfur
deprivation, C. reinhardtii rapidly metabolised extra-cellu-
lar fixed carbon and synthesised the storage compounds
starch and lipids in the form of triacylglycerides (TAGs).
Over the next 96 h hydrogen production was achieved,
peaking at 48 h post sulfur deprivation, while starch
reserves were metabolised. However, amino acid and
fatty-acid biosynthetic capacity and cellular stores
remained intact, suggesting that the observed decline in
hydrogen production was not due to metabolic depletion
but instead because of the toxic accumulation of fermenta-
tion products, formate and ethanol. More recently, Lv et al.
(2013) analysed the transcriptome of C. reinhardtii under
exponential growth and lipid accumulation, identifying
over 2500 genes that were upregulated. Of these 80% were
assigned to functional categories which, as well as lipid
biosynthesis, included several central metabolic pathways,
suggesting an increase in general metabolism in response
to the imposed stress. In addition, 41 transcription factors
were differentially expressed under tested conditions.
Building upon the genomic analyses are several GSMMs
(Reijnders et al., 2014), which facilitate predictive attempts
to harness the biosynthetic capacity of C. reinhardtii. Com-
bined with a legacy of fundamental research and the cur-
rent impetus placed on microalgae as a potentially
sustainable source of energy, these modelling and other
systems biology approaches are leading to an enormous
increase in our understanding of C. reinhardtii, and efforts
to manipulate it. At the same time, there has been a rise in
the number of other microalgae with sequenced genomes
and genomics tools (Figure S1 and Table S1); these data
are leading to a much wider knowledge base of these
organisms generally.
Advanced tools for manipulation of the C. reinhardtii
nucleus
Efforts to express genes in the C. reinhardtii nucleus have
been underpinned by the elucidation of mechanisms to
regulate transgene expression. Examples include the use
of promoters (Table 2) that have been characterised either
as constitutive (e.g. HSP70A/RBCS2; Schroda et al., 2000)
or regulated in response to specific stimuli, such as light
(PSAD; Fischer and Rochaix, 2001), copper (CYC6; Quinn
and Merchant, 1995), nitrate (NIT1; Ohresser et al., 1997),
and most recently vitamin B12 (METE; Helliwell et al.,
2014). RNA-based elements have also been employed to
augment transgene expression (Table 2). Introns of the
Rubisco Small Subunit 2 (RBCS2) have been used exten-
sively since they were first shown to function as enhancer
elements in a manner independent of orientation, and
they are effective when positioned either upstream or
downstream of the promoter (Lumbreras et al., 1998).
Thiamine pyrophosphate riboswitches have been identi-
fied in the thiamine biosynthetic pathway of C. reinhardtii
which cause alternative splicing on binding the ligand,
(Croft et al., 2007). The THI4 riboswitch has subsequently
been used to regulate expression of a nuclear encoded
protein, NAC2, which in turn is required for chloroplast
gene expression (Ramundo et al., 2013). Down-regulation
of native C. reinhardtii genes has taken advantage of RNA
interference, where binding of short fragments of RNA
(microRNA or miRNA) complementary to specific mRNAs
leads to cleavage and thus silencing of the target gene.
C. reinhardtii encodes all the components of the RNAi
pathway (Casas-Mollano et al., 2008), and techniques for
artificial-micro-RNA (amiRNA) have been developed (Mol-
nar et al., 2009; Zhao et al., 2009). In one report, combin-
ing amiRNA with the NIT1 promoter resulted in an
inducible gene knockdown system (Schmollinger et al.,
2010).
Several different reporter genes are available, both fluo-
rescent and colorimetric, and in most instances these have
been modified for expression in C. reinhardtii; the unusu-
ally high GC content of ~65% (Merchant et al., 2007) means
that most heterologous genes need to be codon optimised
before they are expressed efficiently (e.g. Fuhrmann et al.,
1999). Expressed proteins can be directed to different sub-
cellular locations, or for secretion, using characterised tar-
geting peptides, and tags for immunodetection or
purification of expressed proteins have been developed
(Eichler-Stahlberg et al., 2009). Eukaryotic cleavage pep-
tides, such as viral 2A peptides (Rasala et al., 2012), have
been demonstrated to work in C. reinhardtii, thus in princi-
ple allowing expression of two or more proteins from a
single transgene construct. This would overcome potential
difficulties in the limited number of promoters available,
repeated use of which would be likely to increase the prob-
lems of gene silencing.
In the last 2 years, reports of advanced techniques for
genome editing of C. reinhardtii have appeared. The first
demonstration of genome editing was via zinc finger nuc-
leases, which work by fusing a DNA binding domain from
naturally occurring zinc finger nuclease with a DNA cleav-
age domain. Sizova et al. (2013) transformed C. reinhardtii
with a heterologous non-functional APHVIII gene, inter-
rupted with a 24-bp COP3 sequence, the target of the zinc
finger nuclease. Subsequent transformation with the gene
encoding the zinc finger nuclease, expressed from the
HSP70A promoter, and a 120-bp sequence of DNA comple-
mentary to the non-functional region of APHVIII, followed
by selection for paromomycin resistance, generated sev-
eral colonies, indicating restoration of APHVIII gene func-
tion. No spontaneous resistance was apparent in the
controls. The methodology was subsequently used to
introduce targeted mutations into the native COP3 gene.
The second example of genome editing employed Tran-
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scription Activator-Like Effectors (TALE) for specific activa-
tion of target genes (Gao et al., 2014). In this work, the
endogenous arylsulfatase genes, ARS1 and ARS2, were
targeted via their promoters. Nuclear expression of the
respective TALE, from a HSP70A/RBCS2 promoter and
RBCS2 terminator cassette increased the expression of
each ARS at the level of both the transcript and protein, a
fact confirmed by an assay of arylsulfatase activity. Finally
the efficacy of the Clustered Regularly Interspersed Short
Palindromic repeat (CRISPR) system was tested (Jiang
et al., 2014). CRISPR associated protein 9 (CAS9) is an
RNA-guided DNA nuclease that has been employed to
introduce targeted mutations into eukaryotic genomes. No
stable transformants of C. reinhardtii expressing the CAS9
protein could be recovered, suggesting that the protein
was toxic (Jiang et al., 2014). As a result the authors
employed transient expression in an attempt to orchestrate
targeted mutagenesis of four independent gene targets,
HYG, mutant green fluorescent protein (mGFP), Gaussia
luciferase (gLUC) and peptidyl-prolyl cis-trans isomerase
(FKB12). A PCR assay was employed to enrich for and
detect the presence of Cas9 mediated mutations. Although
the system demonstrated low efficiency, with only a single
FKB12 mutant obtained, it provides a benchmark for future
research in this area.
In spite of our ability to manipulate the genome of
C. reinhardtii, few examples of actual metabolic engineer-
ing are available in the literature. Of these, engineered
expression of native genes for diacylglycerol acyltransfer-
ases (DGATs) provides a good example of the current
status. In this, three type-2 DGAT genes were expressed
constitutively with the PSAD promoter and 30UTR, and
their impact on TAG biosynthesis and profile analysed
(La Russa et al., 2012). Although expression varied due
to random integration, DGAT mRNA levels were
increased 1.7- to 29.1-fold compared to controls. In spite
of this no significant increase in lipid biosynthesis was
observed, possibly due to induction of lipid degradation
pathways (Nguyen et al., 2011). A second example is pro-
vided by the attempt to engineer C. reinhardtii to make
the keto-carotenoids, astaxanthin and canthaxanthin. Con-
stitutive expression of a b-carotene ketolase gene (BKT1),
derived from the green microalga Haematococcus pluvial-
is, in the C. reinhardtii nucleus using the RBCS2 pro-
moter, combined with targeting to the chloroplast via
RBCS2 or ferredoxin (FD) transit peptides (Table 2)
resulted in the undesired biosynthesis of 4-keto-lutein
(Leon et al., 2007). Possible reasons for this failure
include lack of substrate accessibility in the thylakoid
membranes where the carotenoids are synthesised, and/
or the inability of the heterologous b-ketolase to integrate
into the carotenogenic enzyme complexes. For both this,
and the example of expression of DGATs, optimisation
would require many different genetic constructs to be
tested, including down-regulation of endogenous path-
ways as well as expression of transgenes in the same
cell line. The current tools available for manipulation of
C. reinhardtii limit considerably the ability to carry out
these combinatorial studies.
Engineering the C. reinhardtii Chloroplast
From an engineering perspective, the chloroplast provides
a unique cellular compartment that harbours numerous
essential processes, including those of biotechnological
importance such as carotenoid and fatty-acid biosynthesis.
The chloroplast genomes of more than 20 species are now
accessible to genetic modification (Day and Goldschmidt-
Clermont, 2011; Maliga, 2012). However, chloroplast engi-
neering is routine for only three species, Nicotiana taba-
cum (Golds et al., 1993), N. benthamiana (Davarpanah
et al., 2009), C. reinhardtii (Blowers et al., 1989). This fur-
ther highlights the importance of C. reinhardtii as an IB
platform. Working with the chloroplast provides a number
of unique advantages, for example, the chloroplast gen-
ome is derived from a cyanobacterial genome that has
been reduced by two orders of magnitude (Scharff and
Bock, 2014). Its prokaryotic origin allows genes to be co-
ordinated into operons, and to integrate DNA in a targeted
manner via homologous recombination, so that mutant
phenotypes can be complemented and resistance markers
recycled to generate ‘marker-less’ strains (Fischer et al.,
1996; Bateman and Purton, 2000) (Table 3). Moreover,
some established bacterial resources also work in the
C. reinhardtii chloroplast, including the lac repressor sys-
tem (Kato et al., 2007). This is useful as it has been
reported that native promoters maybe compromised by
tight regulation of essential photosynthetic processes. For
example, the promoter and 50UTR of the psbA gene, which
encodes the D1 subunit of photosystem II, can only be
used in a psbA-deficient background because of D1-depen-
dent auto-repression (Rasala et al., 2011). In spite of this,
some combinations of promoter and 50UTR have been
identified that achieve efficient transgene expression in
photosynthetic backgrounds, such as the 16S rRNA pro-
moter-atpA 50UTR hybrid (Rasala et al., 2011), and there
are several reports of expression of single proteins being
produced within the C. reinhardtii chloroplast (Tissot-Lecu-
elle et al., 2014). However, examples of metabolic engi-
neering are much fewer in number. The most relevant
example is that of enhanced bio-hydrogen production. Wu
et al. (2011) expressed codon optimised hemH and lba to
enhance cellular respiration, reducing the dissolved oxy-
gen concentration in the media, thereby causing an up reg-
ulation of hydrogenase genes hydA1 and hydA2.
Nonetheless, as with examples in the nucleus, improve-
ments obtained through chloroplast metabolic engineering
are limited compared with what has been achieved in
other biological platforms.
© 2015 The Authors
The Plant Journal published by Society for Experimental Biology and John Wiley & Sons Ltd.,
The Plant Journal, (2015), doi: 10.1111/tpj.12781
6 Mark A. Scaife et al.
HARNESSING BIOLOGICAL SYSTEMS FOR TECHNOLOGY
Industrial biotechnology employs biological systems,
mainly microbes, for the production of commodities.
Today these range from fuels, to platform chemicals, and
many high-value products, including a vast range of thera-
peutics and pharmaceuticals. IB has its origins in fermenta-
tion practices for beer, wine and breadmaking, but as
microbiology emerged as a science, the ability to control
these technologies proceeded in parallel, and led to many
important compounds being made this way (reviewed in
Buchholz and Collins, 2013). A noteworthy example is pen-
icillin from the fungus Penicillium notatum, as well as sev-
eral other naturally occurring antibiotics from soil bacteria.
The advent of genetic manipulation enabled the optimisa-
tion of biological production systems and enormously
expanded the portfolio of compounds that could be pro-
duced by IB, including the ability to produce human insulin
and growth hormone as recombinant proteins, avoiding
the side effects of use of animal forms of the hormones
(Vajo et al., 2001). Today, as well as pharmaceuticals, prod-
ucts from IB are an everyday feature of life, from vegetar-
ian cheeses made with recombinant rennet, to plastics
made from platform chemicals, to enzymes in washing
powders (Goel et al., 2012).
The best known IB platforms are E. coli and S. cerevisi-
ae, their utility being derived from decades of research that
has progressed through various stages, ranging from the
introduction of individual genes using standard expression
systems, to the regulation of complex biochemical
pathways using highly regulated genetic circuits (Figure 2).
Parallel to the development of tools for manipulation, the
application of systems biology and GSMMs have enabled
rational modification of discrete pathways (Yu et al., 2011;
Chen and Zeng, 2013), whilst improvement of platform
strains with respect to growth and productivity within the
fermenter, as well as downstream processing, has led to
optimised hosts for different bioprocesses (Goel et al.,
Table 3 Regulatory elements available for the C. reinhardtii chloroplast. Chloroplast functional parts are classified as transcriptional leaders
(promoter and 50UTR), chloroplast-targeted peptides, selectable markers and destination sequences for homologous recombination
Functional element Name Properties Source
Transcriptional leaders AtpA, psbD Constitutive expression Barnes et al. (2005)
psaA-exon1 Strong expression Michelet et al. (2011)
Chloroplast-targeted
peptides
psaD 35 aa N-terminal Fischer and Rochaix (2001)
rbcS2, FD 32 aa N-terminal Leon et al. (2007)
Selectable marker rrnS and rrnL
point mutations
Spectomycin and erythromycin
resistance
Kindle et al. (1991)
arg9 Arginine complementation Remacle et al. (2009)
aadA Spectinomycin resistance Goldschmidt-Clermont (1991)
aphA6 Resistance kanamycin Bateman and Purton (2000)
GFP Fluorescent reporter Franklin et al. (2002)
gusA b-Glucuronidase activity Sakamoto et al. (1993)
atpB 5-Fluorodeoxyuridine resistance Kindle et al. (1991)
coda Cytosine deaminase sensitivity
to 5-fluorocytosine
Young and Purton (2014)
Destination sequences
for homologous
recombination
p322 psbA and 16S rRNA Manuell et al. (2007),
Barnes et al. (2005)
patpint-cg11 (atpB-int) Inverted repeat and atpB 30UTR Nickelsen et al. (1994)
pLM7 (IR-int) psbA and 5S/23S Michelet et al. (2011)
p72B psbH and psbN Bateman and Purton (2000)
p71 tscA and inverted repeat Kindle et al. (1991)
Figure 2. Schematic of host optimisation via metabolic engineering and
synthetic biology.
The chronologic development of a biological host via metabolic engineering
(blue), including the recent advent of systems biology and genome-scale
metabolic models. Synthetic biology (red) has the potential to expedite this
process in new biological systems, including microalgae, providing an
opportunity to proceed directly from basic knowledge and capacity to the
generation of highly optimised productive hosts.
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2012). This progression is demonstrated by the work on
the optimisation of E. coli strains expressing a gene encod-
ing amorphodiene synthase from Artemisia annua, which
catalyses the conversion of the isoprenoid intermediate
farnesyl pyrophosphate into amorphodiene. Starting with
a landmark metabolic engineering paper, Martin et al.
(2003) introduced a yeast mevalonate pathway into E. coli
to enhance production of the isoprenoid precursor,
isopentenyl pyrophosphate. This increased amorphodiene
biosynthesis 36-fold, to 24 lg mL1. This strain was
employed in several subsequent studies to achieve
iterative improvements in target compound production by
elucidating metabolic limitations in precursor biosynthesis
and improving carbon flux towards the end products. First,
expression of the mevalonate pathway gene 3-hydroxy-
3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase was
modulated to improve precursor biosynthesis leading to a
three-fold (ca. 70 lg mL1) increase over the original strain
(Pitera et al., 2007). Following this, mevalonate kinase
and amorphadiene synthase were identified as rate
limiting, and optimisation of promoter strength and gene
copy number increased productivity seven-fold (ca.
160 lg mL1) over the original construct (Anthony et al.,
2009). This moved the metabolic bottleneck back to HMG-
CoA reductase, and the introduction and optimisation of
an alternative HMG-CoA reductase, derived from Delftia ac-
idovorans, led to levels of 700 lg mL1 amorphodiene (Ma
et al., 2011). Most recently, Dahl et al. (2013) identified
farnesyl pyrophosphate as a toxic intermediate and intro-
duced dynamic control to regulate its synthesis and con-
sumption. The application of systems biology methods
identified promoters induced in response to intermediate
accumulation, and these were employed to drive the
expression of both the farnesyl pyrophosphate biosynthet-
ic pathway and the amorphadiene biosynthetic genes,
resulting in a doubling of the amorphadiene titre, to
1.6 mg mL1. This approach is now routine in IB where
iterative improvements enable optimisation of inputs and
gene expression to maximise the economic viability of a
bioprocess.
Tangential to these developments has been the rise of
synthetic biology. Much of the current focus of this disci-
pline is on the development and analysis of genetic cir-
cuits, emergent behaviour and minimal genomes (Juhas
et al., 2011), as well as the generation of non-natural bio-
logical systems with an expanded genetic code (Neumann
and Neumann-Staubitz, 2010). Nonetheless, the potential
for synthetic biology to contribute to IB is significant (Kha-
lil and Collins, 2010; Yadav et al., 2012).
SYNTHETIC BIOLOGY ALLOWS RATIONAL DESIGN OF
BIOLOGICAL SYSTEMS
Synthetic biology draws on principles first employed in the
electronics field, and aims to create or (re)design complex
biological circuits, networks or whole organisms in a
rational way, combining computational models with assem-
bly of standard or modularised components, to create use-
ful outputs. Synthetic biology is characterised by an
iterative workflow of continuous improvement, with gener-
ated knowledge informing subsequent rounds of design
(shown schematically in Figure 3a). The basis is the use of
standard parts (Figure 3b) for the design and engineering of
novel biological systems, in this example DNA sequences
such as promoters, terminators or introns. These parts or
pathways may be described as orthogonal, that is they are
transferrable between different cellular hosts with little/no
impact on function (i.e. platform independent). They may
be insulated, so they are unaffected by host cell metabo-
lism, while an approach may be said to lead to abstraction,
allowing design at higher levels of complexity because
work builds upon well characterised inputs. This makes
knowledge transferable, as a combination of elements that
lead to a predetermined expression level of a transgene
could be employed in subsequent studies to drive the
expression of other transgenes. The aim is that, once suffi-
ciently well characterised, the design process no longer
needs to consider individual DNA parts. Instead these
may be combined into expression cassettes or devices
(Figure 3c) with novel but predictable outputs. This will
allow the field to progress more efficiently by building
directly upon work that preceded it. Table 4 provides a sum-
mary of other commonly used synthetic biology terms.
Synthetic biology in action – Escherichia coli
Escherichia coli is the best understood and most advanced
biological platform available, demonstrating great utility
for the development of ground-breaking molecular, genetic
and biochemical techniques. As such it has been widely
employed to pioneer synthetic biology (Cameron et al.,
2014). For example, there is now a Registry of Standard
Biological Parts, or Biobricks (Knight, 2003), the number of
which now exceeds 12 000 (Vilanova and Porcar, 2014).
Public access allows researchers to explore novel function-
alities and applications, in return for contributing to the
centralised knowledge database. This foundation provides
the ability to engineer strains and create genetic circuits,
such as the use of a two-component sensor and response
system where genes were regulated in response to differ-
ent light wavelengths (Olson et al., 2014). The system was
composed of a histidine kinase with an N-terminal phyto-
chrome domain sensor and a C-terminal bifunctional
kinase-phosphatase signalling domain. Using biological
information and modelling, the system was manipulated
to regulate protein expression in response to different
wavelengths and pulse profiles of light using an auto-
mated illumination program. The binary states demon-
strated by this system provide a basis for future logic
based gene circuits.
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Escherichia coli synthetic biology has already advanced
to population-scale regulation using synthetic networks.
An example of this is the synchronisation of genetic clocks
by post-translational events. Prindle et al. (2014) employed
intracellular negative-feedback and a quorum-sensing
oscillator in combination with proteins tagged for rapid
protease catalysed degradation via the CLPXP signal. By
coupling these processes the authors engineered a system
in which the response delay was reduced by an order of
magnitude over systems coupled at the level of transcrip-
tion. Modification of the linker sequence length between
the peptide and the degradation tag made the timing of
the response tunable, offering the potential to create opti-
mised expression profiles for synthetic gene circuits. As an
illustration, a useful application of this for metabolic engi-
neering would be regulation of key mevalonate biosynthe-
sis genes in the amorphodiene strain discussed above.
Synthetic biology in action – Saccharomyces cerevisiae
The major chassis in eukaryotes is S. cerevisiae. This uni-
cellular yeast benefits from numerous community
resources that support fundamental research, including
knock-out collections in which each protein-coding region
has been systematically disrupted both individually (Dujon,
1998; Winzeler et al., 1999), and in pairs (Tong et al., 2001),
allowing investigation of lethality and gene relationships.
Aspects of S. cerevisiae research have moved to adopt the
principles of synthetic biology. A pioneering example of
this is the creation of an entirely artificial yeast chromo-
some (Annaluru et al., 2014), engineered to streamline and
condense the encoded genetic information and allow re-
organisation of coding regions on a massive scale. This
paves the way for rapid laboratory-based evolution to gen-
erate novel phenotypes with biotechnological relevance.
Further examples of how synthetic biology has been
applied to S. cerevisiae include the development of novel
synthetic inducible promoters, regulated by a ligand that
does not influence cell physiology (i.e. is insulated), which
are also tunable. McIsaac et al. (2014) constitutively
expressed an artificial transcription factor (ATF) in a cell
line harbouring a green fluorescent protein (GFP) reporter
that was regulated via a synthetic promoter containing one
or several binding sites for the ATF. The reporter was
expressed in the presence of the inducer, b-estradiol, and
modification to the number and position of the ATF bind-
ing sites provided tunable expression upon induction, with
a dynamic range that spanned three orders of magnitude.
In another study, Yofe et al. (2014) investigated the abil-
ity of non-coding sequences to regulate gene expression in
S. cerevisiae. Creating a library of 240 reporter lines, each
containing a different intron within the reporter gene cod-
ing sequence, the authors observed variation in expression
spanning 100-fold. These lines demonstrated robustness in
expression level and a capacity for tunable gene expres-
sion, achieved through the modification of key intron
motifs and/or the folding energy of the intron-exon bound-
ary. Finally, to allow rational design, the authors developed
a computational model that fitted the experimental perfor-
mance of tested sequences.
To demonstrate the power of a combinatorial approach,
the five genes of the uncharacterised violacein biosynthetic
pathways were targeted. In this, five promoters which
spanned nearly three orders of magnitude in expression
level were employed to drive expression of the violacein
biosynthetic genes from BBa_K274002, a plasmid from the
Registry of Standard Biological Parts (Knight, 2003). A
rapid PCR genotyping method combined with computa-
tional modelling to integrate experimental data enabled
Table 4 Summary of common synthetic biology terms
Keyword Description
Abstraction Through standardisation of individual parts these may be combined into simple devices with predictable outputs,
combination of these devices allows design at a higher level of complexity, i.e. circuits or systems.
This is the concept of abstraction
Boolean logic gates An engineering principle in which an output is dependent on one or more specific inputs, and where the
output is 1 or 0, true or false, on or off
Chassis The framework on which to base the standardised parts. Effectively, a host organism into which standard genetic
constructs can be introduced easily
Device A DNA construct incorporating required part(s) for desired expression of a transgene
Modularity A design concept in which parts are considered as discrete elements. Characterised parts can be combined to
create an expression cassette which, due to its predictable function, is considered a modular element in its
own right, becoming a part
In-silico modelling The application of informed metabolic models to inform experimental design and allow hypothesis-driven
research into complex systems
Orthogonal The function of a DNA part independently of: (i) cellular platform; and/or (ii) cellular context
Part(s) DNA sequence(s) that encode a biological function, e.g. promoter, intron, 30UTR, reporter gene
Standardisation The application of uniformed strategies to assess, characterise or validate biological parts or processes.
Examples include assembly protocols, reporter assays, or selection methods
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the prediction of pathway compositions that would mini-
mise intermediate accumulation and/or maximise violacein
biosynthesis. In doing so the authors demonstrated path-
way optimisation without prior knowledge of absolute pro-
tein or metabolite levels, enzyme kinetics or
thermodynamics, or even the order of the reactions (Lee
et al., 2013).
DEVELOPMENT OF A C. REINHARDTII INDUSTRIAL
BIOTECHNOLOGY PLATFORM
The approaches presented above provide an overview of
what is currently possible with well characterised IB plat-
forms, and how a synthetic biology approach would aug-
ment both the range and amount of compounds that could
be produced, and the rate of progress. For C. reinhardtii,
although our ability to manipulate it genetically is advanc-
ing rapidly, many limitations remain for effective metabolic
engineering. For example, fewer than 100 protein-coding
genes from the C. reinhardtii genome have been function-
ally validated, compared with the approximately 6800
genes that have been characterised experimentally in Ara-
bidopsis thaliana (Koornneef et al., 2004). Additionally, the
number of tools to regulate transgene expression (Tables 2
and 3) is small compared with standard IB hosts. There are
also the well known complications of integration of transg-
enes into the nucleus via non-homologous end joining,
and extensive gene silencing. A significant additional chal-
lenge is the fact that regulatory networks at the genetic,
cellular, and metabolic levels in C. reinhardtii are almost
completely unexplored, so that attempts at manipulation
will be effectively empirical, whereas there are many stud-
ies of the interactome of E. coli (Juan et al., 2008) and
S. cerevisiae (Ito et al., 2001). Although undoubtedly some
of these knowledge gaps for C. reinhardtii will be filled in
the near future (as discussed above), it should be noted
that no biological chassis evolved to be optimal for scien-
tific research, with extensive engineering required to create
today’s E. coli strains for routine protein expression (Goel
et al., 2012; Buchholz and Collins, 2013). Thus rather than
waiting for this to be true for C. reinhardtii, would it be
possible to expedite progress by applying current leading
concepts, techniques and technologies from synthetic biol-
ogy? This might lead to quicker solutions to current
research questions and, importantly, provide the opportu-
nity to develop C. reinhardtii production systems that
exceed the capacity of current metabolic engineering
approaches. Adopting standardisation, modularity, and
design/testing does not require drastic changes in
approach, nor does it render all prior knowledge obsolete.
Instead this progression can be achieved by subtle
changes to minimise experimental variables and standard-
ise workflows, creating a cycle of perpetual improvement.
To demonstrate this, let us consider an example of
improved TAG biosynthesis for biodiesel production
(Figure 4). When cultured under diurnal conditions, i.e.
with a light/dark photoperiod, C. reinhardtii will photosyn-
thesise during the light, fixing carbon dioxide and storing
any excess as starch. In the dark the accumulated starch is
consumed to support cellular activity. When exposed to
nutrient stress, such as nitrogen depletion, C. reinhardtii
accumulates much higher amounts of storage molecules,
(a)
(b)
(c)
Figure 3. Schematic representation of a synthetic biology workflow.
An example investigation may aim to increase metabolite x through heterol-
ogous expression of gene y. Prior to this knowledge must be generated to
describe the function of individual parts, promoters, 50UTRs, transit pep-
tides (TP), (trans)genes of interest (GOI) and 30UTRs, and/or introns to
enhance mRNA stability. Achieved through progress from design through
construction application and analysis (including in silico models), when
completed in a standardised manner this represents a single iteration of the
cyclic process (a). The completion of several rounds of characterisation gen-
erates the knowledge required assign functional parameters to individual
(generic) parts. These parts can be considered in a discrete manner (b) pro-
viding the opportunity to deconstruction of complex modules and recom-
bine the parts a rational manner to generate novel functional devices (c)
that have a predictable output.
© 2015 The Authors
The Plant Journal published by Society for Experimental Biology and John Wiley & Sons Ltd.,
The Plant Journal, (2015), doi: 10.1111/tpj.12781
10 Mark A. Scaife et al.
principally starch and TAG (Merchant et al., 2012). Under
conditions where the desired product is TAG, starch bio-
synthesis may be considered an undesired carbon sink.
This principle was demonstrated through the analysis of
mutants deficient in starch biosynthesis (Wang et al.,
2009). However, starchless mutants are not able to be
propagated under diurnal conditions because they lack the
required starch to survive periods of darkness (Davey
et al., 2014). To overcome this and optimise TAG produc-
tion one may therefore consider a synthetic circuit that
links nitrogen depletion and starch biosynthesis in a man-
ner that would enhance carbon flux into TAG production
only under nitrogen stress (shown schematically in Fig-
ure 4a). Employing the workflow presented in Figure 3, a
regulatory system could be identified and used to regulate
the expression of a starch biosynthesis gene in response
to light or nitrogen depletion. Once suitable elements are
identified data describing expression characteristics could
be integrated into an in silico model to generate predicted
outputs (Figure 4b), and then tested to find the optimal
combination of parts for the device. The next stage would
be to engineer the system such that TAG production was
induced independently of nitrogen depletion. Complemen-
tation of a starchless phenotype using this regulatory
system would restore starch biosynthesis to that of a wild-
type strain, with expression induced in response to light
availability (input; light). Because the same system would
be down-regulated in response to nitrogen stress (input;
nitrogen depletion), this would over-ride the light-based
regulation (OR gate logic). The designed circuit would,
when exposed to nitrogen stress, suppress starch biosyn-
thesis as native TAG production pathways are induced,
producing more TAG because of increased fixed carbon
availability.
CONCLUSION
Microalgae are of interest to academic and commercial
stakeholders due to their unique biology, which encom-
passes facets of bacterial and yeast systems, and their
potential as a biotechnology platform. Although the micro-
algal research field is less well developed than for the for-
mer organisms, the model green alga, C. reinhardtii, is
positioned for development as an IB platform. It is evident
that the major limitation now lies in our capacity to engi-
neer C. reinhardtii efficiently. By taking a synthetic biology
approach, progress within the field should be accelerated.
One final point to make is that the diversity of microal-
gae means that C. reinhardtii does not provide all of the
attributes assigned to ‘microalgae’. That said, its develop-
ment as an IB platform would undoubtedly benefit the
entire microalgal community, and pave the way for subse-
quent more efficient development of alternative microalgal
hosts of biotechnological importance, including P. tricor-
nutum, Thalassiosira pseudonana, O. tauri and Nanno-
chloropsis spp. (Table S1). These will offer a wider range
of products, and possibly other advantages such as homol-
ogous recombination, which has been reported for the lat-
ter two species. It is important to acknowledge that
although E. coli and S. cerevisiae are the best known IB
platforms, many other bacteria and yeasts are employed in
million dollar biotechnology sectors for the production of
value-added products. The time is right to consider extend-
ing this to microalgae to address the desire to improve the
sustainability of these processes (Langevels et al., 2010).
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